No Data
Guangzhou Baiyunshan Pharmaceutical Subsidiary Gets Approval to List on China's NEEQ Market
Guangzhou Baiyunshan Pharmaceutical Unit's Antibiotic Passes Generic Consistency Evaluation
Baiyunshan: Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Report for the first quarter of 2025
Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Report for the first quarter of 2025
Guangzhou Baiyunshan Pharmaceutical's Q1 Profit Slides 7%
BAIYUNSHAN PH (00874) recommends appointing Cheng Hongjin and Tang Heping as executive directors of the Ninth Board of Directors.
BAIYUNSHAN PH (00874) released an announcement, the Board of Directors recommends appointing Cheng Hongjin and Tang Heping as the executive directors of the company's ninth Board of Directors...
Returns At Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) Appear To Be Weighed Down